Thomas Mccourt, CEO, Director at Ironwood Pharma, holds 1.15M shares in Ironwood Pharma (Ticker: IRWD), holds 0.00 shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Pliant Therapeutics (Ticker: PLRX). Most recently, Thomas Mccourt Sold ― shares of Ironwood Pharma on May 22, 2024 for an estimated value of 436.14K.